Editorial: Metabolic Supplementation with Orotic Acid and Magnesium Orotate

Abstract

Orotic acid (OA), a naturally occurring substance, is a key intermediate in the biosynthetic pathway of pyrimidines. Previous investigations in the heart suggest that orotate can protect recently infarcted hearts against a further ischemic stress and may be beneficial in certain types of experimental cardiomyopathy. At the Hamburg symposium on magnesium orotate, a number of studies of this form of metabolic supplementation were presented that indicate orotic acid and its magnesium salt have a modest beneficial effect on the myocardium under conditions of stress ranging from myocardial infarction to severe physical exercise. The following conclusions can be drawn: (1) Orotic acid can improve the energy status of the recently infarcted myocardium (rat hearts). (2) Orotic acid may improve myocardial purine and pyrimidine levels by stimulating hepatic release of uridine into the bloodstream, which in turn augments depleted myocardial pyrimidines and purines (rat heart). (3) Orotic acid improves the tolerance of the recently infarcted heart to global ischemia (rats). (4) Magnesium orotate may reduce the severity of chronic myocardial dysfunction and structural damage in cardiomyopathy (cardiomyopathic hamsters). (5) Magnesium orotate may improve exercise tolerance in patients with coronary artery disease and in trained athletes (humans). (6) Magnesium orotate has only a weak inotropic effect, if any, on normal hearts (rats). (7) Further clinical testing is indicated to determine if the effects described could be of significant clinical benefit in the treatment of heart disease.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Rundles RW, Brewer SS. Haematologic responses in pernicious anemia to orotic acid. Blood 1958;13:99-115.

    Google Scholar 

  2. 2.

    Schwarze R, Kintzel, HW, Hinkel GK. The influence of orotic acid on the serum bilirubin level of mature newborn. Acta Paediatr Scand 1971;60:705-708.

    Google Scholar 

  3. 3.

    Pavesio D, Pecco P, Imdicello P. Fructose-induced hyperuricaemia and its compensation by the healthy infant. Minerva Pediatr 1972;24:125-132.

    Google Scholar 

  4. 4.

    Windmueller HG, Levy RI. Total inhibition of hepatic betalipoprotein production in the rat by orotic acid. J Biol Chem 1967;242:2246-2254.

    Google Scholar 

  5. 5.

    Meerson FZ. The myocardium in hyperfunction, hypertrophy and heart failure. Circ Res 1969;24/25(Suppl. 2): II146-II155.

    Google Scholar 

  6. 6.

    Meerson FZ, Rosanova LS. Effect of 2703 actinomycin and combination of nucleic acid synthesis activators on the development of fatigue and fitness. Dokl Akad Nauk SSSR 1967;166:496-499.

    Google Scholar 

  7. 7.

    Simonson E, Berman R. New approach in treatment of cardiac decompensation in USSR. Am Heart J 1973;86:117-123.

    Google Scholar 

  8. 8.

    Chazov E, personal communication, 1995.

  9. 9.

    Williams JF, Donohoe J, Lykke A, Kolos G. Studies using orotic acid for improving the controlled development of myocardial hypertrophy. Aust N Z J Med 1976;6(Suppl. 2):60-71.

    Google Scholar 

  10. 10.

    Donohoe JA, Williams JF, Kolos G, Hickie JB. The action of orotic acid as a positive inotropic agent during the acute phase of myocardial hypertrophy. Aust N Z J Med 1974; 4:542-548.

    Google Scholar 

  11. 11.

    Donohoe JA. The Role of Orotic Acid in the Acutely Stressed Myocardium. PhD Thesis. Australian National University, 1977.

  12. 12.

    Donohoe JA, Rosenfeldt FL, Munsch CM, Williams JF. The effect of orotic acid treatment on the energy and carbohydrate metabolism of the hypertrophying rat heart. Int J Biochem 1993;25:163-182.

    Google Scholar 

  13. 13.

    Newman MAJ, Chen X-Z, Rabinov M, Williams JF, Rosenfeldt FL. Sensitivity of the recently infarcted heart to cardioplegic arrest. J Thorac Cardiovasc Surg 1989;97: 593-604.

    Google Scholar 

  14. 14.

    Munsch C, Williams JF, Rosenfeldt FL. The impaired tolerance of the recently infarcted rat heart to cardioplegic arrest: The protective effect of orotic acid. J Mol Cell Cardiol 1989;21:751-754.

    Google Scholar 

  15. 15.

    Munsch CM, Rosenfeldt FL, O'Halloran K, Langley LH, Conyers RAJ, Williams JF. The effect of orotic acid on the response of the recently infarcted rat heart to hypothermic cardioplegia. Eur J Cardiothorac Surg 1991;5:92-93.

    Google Scholar 

  16. 16.

    Munsch CM, Williams JF, Conyers RAJ, O'Halloran K, Langley LH, Rosenfeldt FL. The effect of orotic acid and ribose on the impaired tolerance of the recently infarcted rat heart to cardioplegic arrest. In: Williams JF, ed. Orotic Acid in Cardiology. New York: Thieme Medical, 1992:46-58.

    Google Scholar 

  17. 17.

    Cochrane AD, Pathik S, Smolich JJ, Conyers RAJ, Rosenfeldt FL. Depressed function in non-infarcted myocardium after recent myocardial infarction: Influence of orotic acid. Ann Thorac Surg 1996;62:1765-1772.

    Google Scholar 

  18. 18.

    Bailey LE. Orotic acid prevents changes in cardiac sarcolemmal glycoproteins and contractility associated with muscular dystrophy in hamsters. Experientia 1980;36:6-7.

    Google Scholar 

  19. 19.

    Bajusz E, Baker JR, Nixon CW, Homburger F. Spontaneous, hereditary myocardial degeneration and congestive heart failure in a strain of Syrian hamsters. Ann NY Acad Sci 1969;156:105-129.

    Google Scholar 

  20. 20.

    Zimmer H-G. Effects of magnesium orotate on rat heart function. Cardioscience 1994;5:55-61.

    Google Scholar 

  21. 21.

    Bajusz E, Homburger F, Baker JR, Bogdonoff P. Dissociation of factors influencing myocardial degeneration and generalized cardiocirculatory failure. Ann NY Acad Sci 1969; 156:396-420.

    Google Scholar 

  22. 22.

    Golf S, Happel O, Graef V. Plasma aldosterone, cortisol and electrolyte concentrations in physical exercise after magnesium supplementation. J Clin Chem Clin Biochem 1984;22: 797-721.

    Google Scholar 

  23. 23.

    Yeh T Jr., Rebeyka IM, Jakoi ER, Johnson DE, Dignan RJ, Dyke CM, Weschler AS. Orotic acid improves left ventricular recovery four days after heterotopic transplantation. Ann Thorac Surg 1994;58:409-415.

    Google Scholar 

  24. 24.

    Zimmer H-G, Schneider A. Nucleotide precursors modify the effects of isoproterenol. Studies on heart function and cardiac adenine nucleotide content in intact rats. Circ Res 1991;69:1575-1582.

    Google Scholar 

  25. 25.

    Oldfield GS, Commerford PJ, Opie LH. Effects of preoperative glucose-insulin-potassium on myocardial glycogen levels and on complications of mitral valve replacement. J Thorac Cardiovasc Surg 1986;91:874-878.

    Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Rosenfeldt, F.L. Editorial: Metabolic Supplementation with Orotic Acid and Magnesium Orotate. Cardiovasc Drugs Ther 12, 147–152 (1998). https://doi.org/10.1023/A:1007732131887

Download citation

  • orotic acid
  • orotic
  • heart
  • cardiomyopathy
  • metabolism